sign in · help · news · about ·

BibSonomy :: user :: kanefendt ::

tag user group author concept BibTeX key search:all search:kanefendt

The blue social bookmark and publication sharing system.

>
|
<

bookmarks

bookmarks per page: 5 10 20 50 100

RSS BibTeX RDF more

publications

(15)

<< < 1 > >>

Appropriate calibration curve fitting in ligand binding assays
J. W. Findlay, and R. F. Dillard AAPS.J. 9(2):E260-E267 (2007)
to & Algorithms Analytical Binding Calibration Chemistry Dose-Response Drug Ligands Models Pharmaceutical Pharmacokinetics Preparations Protein RANGE Relationship Reproducibility Research Results Sensitivity Specificity Statistical analysis and data metabolism methods numerical of response statistics by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Angiogenesis: an organizing principle for drug discovery?
J. Folkman Nat.Rev.Drug Discov. 6(4):273-286 (2007)
to Agents Angiogenesis Animals Antineoplastic Blood Endothelium Humans Inhibitors Neoplasms Neovascularization Pathologic Physiologic Platelets RANGE Research drug effects genetics pathology pharmacology physiology therapeutic therapy use by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy
J. M. Ebos, C. R. Lee, J. G. Christensen, A. J. Mutsaers, and R. S. Kerbel Proc.Natl.Acad.Sci.U.S.A 104(43):17069-17074 (2007)
to & A Administration Agents Angiogenesis Animals Antineoplastic Antitumor Assays Blood Cell Dose-Response Drug Endothelial Factor Female Growth Humans Hypoxia Indoles Inducing Line Mice Model Neoplasms Organ Outcome Placenta Pregnancy Proteins Pyrroles RANGE Receptor-2 Relationship Research Schedule Scid Specificity Treatment Tumor Tyrosine Vascular Xenograft administration blood dosage drug effects metabolism pathology pharmacology protein response therapy toxicity by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Phase I dose escalation study of telatinib BAY 57-9352 in patients with advanced solid tumours
D. Strumberg, B. Schultheis, I. A. Adamietz, O. Christensen, M. Buechert, J. Kraetzschmar, P. Rajagopalan, M. Ludwig, A. Frost, S. Steinbild, M. E. Scheulen, and K. Mross Br.J.Cancer 99(10):1579-1585 (2008)
to & 80 Adult Aged Agents Angiogenesis Antineoplastic Carcinoma Dose Female Growth Humans Hypertension Imaging Inhibitors Magnetic Male Maximum Medical Middle Neoplasms Oncology Plasma Pyridazines Pyridines RANGE Resonance Tolerated Tyrosine administration and blood dosage drug over response therapy by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Harmonization of strategies for the validation of quantitative analytical procedures: A SFSTP proposal Part IV. Examples of application
P. Hubert, J. J. Nguyen-Huu, B. Boulanger, E. Chapuzet, N. Cohen, P. A. Compagnon, W. Dewe, M. Feinberg, M. Laurentie, N. Mercier, G. Muzard, L. Valat, and E. Rozet J.Pharm.Biomed.Anal. 48(3):760-771 (2008)
to Chemistry Chromatography Control Laboratories Quality RANGE Research methods by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Evaluation of logistic and polynomial models for fitting sandwich-ELISA calibration curves
R. A. Herman, P. N. Scherer, and G. Shan J.Immunol.Methods 339(2):245-258 (2008)
to Assay Calibration Enzyme-Linked Immunosorbent Models Proteins RANGE Theoretical methods protein standards by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis
J. W. Lee, and M. Hall J.Chromatogr.B Analyt.Technol.Biomed.Life Sci. (2008)
to Binding Population Prognosis RANGE States United diagnosis methods protein by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo?
W. Wynendaele, R. Derua, M. F. Hoylaerts, A. Pawinski, E. Waelkens, E. A. Bruijn, R. Paridaens, W. Merlevede, and A. T. van Oosterom Ann.Oncol. 10(8):965-971 (1999)
to A Adult Aged Assay Biological Endothelial Enzyme-Linked Factor Factors Female Growth Humans Immunosorbent Lymphokines Male Markers Middle Neoplasms Neovascularization Nonparametric Pathologic RANGE Reference Research Sensitivity Specificity Statistics Tumor Values Vascular analysis and blood diagnosis methods by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Human anti-animal antibody interferences in immunological assays
L. J. Kricka Clin.Chem. 45(7):942-956 (1999)
to Animals Antibodies Antibody Body False Fluids Human Humans Immunoassay Laboratories Mice Monoclonal Negative Population Positive RANGE Reactions Specificity analysis immunology methods pathology response standards therapy by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
The effects of common matrices for assay standards on performance of ültra sensitive" immunometric assays for TSH. Report of a joint WHO/IFCC collaborative study
R. E. Gaines-Das, H. Brettschneider, and A. F. Bristow Ann.Biol.Clin.Paris 49(10):522-527 (1991)
to Calibration Humans Hyperthyroidism Hypothyroidism Immunoassay Laboratories RANGE Sensitivity Specificity Thyrotropin and blood methods response standards by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Application of the four-parameter logistic model to bioassay: comparison with slope ratio and parallel line models
A. Volund Biometrics 34(3):357-365 (1978)
to Assay Biological Dose-Response Drug Immunoassay Models RANGE Relationship analysis methods response by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Different efficacy of various blocking reagents to eliminate interferences by human antimouse antibodies with a two-site immunoassay
J. Reinsberg Clin.Biochem. 29(2):145-148 (1996)
to Analysis Animals Antibodies Antigen Blocking Blood CA-125 Chemical Evaluation False Heterophile Human Humans Immunoassay Indicators Mice Positive RANGE Reactions Reagents Studies Topic and as blood methods by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Immunodetection and quantification of vascular endothelial growth factor receptor-3 in human malignant tumor tissues
H. Bando, M. Brokelmann, M. Toi, K. Alitalo, J. P. Sleeman, B. Sipos, H. J. Grone, and H. A. Weich Int.J.Cancer 111(2):184-191 (2004)
to Animals Antibodies Assay Carcinoma Cells Chemistry Cultured Distribution Endothelial Enzyme-Linked Factor Goats Growth Human Humans Immunosorbent Kidney Ligands Lung Mice Monoclonal Neoplasms Neovascularization Pathologic RANGE Receptor-3 Research Sensitivity Specificity Tissue Tumor Vascular analysis and cells diagnostic immunology methods pathology protein use by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma
K. Werther, I. J. Christensen, and H. J. Nielsen Br.J.Cancer 86(3):417-423 (2002)
to 80 A Adult Aged Biological Carcinoma Colonic Colorectal Endothelial Factor Factors Female Growth Humans Lymphokines Male Markers Middle Neoplasm Neoplasms Plasma RANGE Rate Rectal Reference Research Staging Survival Time Tumor Values Vascular and blood mortality over pathology surgery by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)
Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays
F. M. Belgore, A. D. Blann, and G. Y. Lip Clin.Sci.Lond 100(5):567-575 (2001)
to A Aged Antibodies Assay Cardiovascular Diseases Endothelial Endothelium Enzyme-Linked Extracellular Factor Factors Female Growth Human Humans Immunoassay Immunosorbent Lymphokines Male Matrix Middle Monoclonal Proteins RANGE Receptor-1 Reproducibility Research Results Sensitivity Solubility Specificity Thrombosis Tyrosine Vascular and blood immunology methods of protein by kanefendt on Feb 5, 2010, 11:28 AM
URL | BibTeX (0)

<< < 1 > >>publications per page: 5 10 20 50 100

a gripper